Premium
A retrospective cohort study comparing microwave endometrial ablation with levonorgestrel‐releasing intrauterine device in the management of heavy menstrual bleeding
Author(s) -
Henshaw Richard,
Coyle Christy,
Low Stephanie,
Barry Christopher
Publication year - 2002
Publication title -
australian and new zealand journal of obstetrics and gynaecology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.734
H-Index - 65
eISSN - 1479-828X
pISSN - 0004-8666
DOI - 10.1111/j.0004-8666.2002.00205.x
Subject(s) - medicine , levonorgestrel , endometrial ablation , retrospective cohort study , menstrual bleeding , intrauterine device , obstetrics , patient satisfaction , cohort , menstruation , gynecology , metrorrhagia , population , ablation , family planning , surgery , research methodology , environmental health
Objective To compare microwave endometrial ablation (MEA TM ) with a levonorgestrel‐releasing intrauterine device (Mirena®) in the management of heavy menstrual bleeding. Design A retrospective cohort study. Sample Thirty‐nine women were treated with MEA TM and 23 women with Mirena®, in the South East Regional Health Service of South Australia during 1998 to 2001; the mean duration of follow‐up was 14.6 months. Main outcome measures Primary measures include acceptability of the treatment process, effectiveness of the treatment, and satisfaction with outcomes. Secondary measures included side effects, complications and quality of life (using the SF‐36). Results Acceptability of the treatment process and satisfaction with outcomes was very high for both procedures. Each treatment led to a statistically significant reduction in menstrual bleeding (p < 0.0001) and dysmenorrhoea scores (p < 0.002). Conclusions There were no statistical differences between the two treatments for any of the primary or secondary outcome measures assessed. The treatments seem equally effective in the management of heavy menstrual loss.